{"disease":{"id":"relapsed-refractory-immune-thrombocytopenia","name":"relapsed refractory immune thrombocytopenia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05599880","title":"The Investigate Efficacy and Safety Evaluation of Bortezomib in Patients With Relapsed/Refractory Immune Thrombocytopenia","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":29,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT07072247","title":"RN1201 Injection in the Treatment of Antibody-Mediated Diseases","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":9,"lead_sponsor_name":"The First Affiliated Hospital of Soochow University","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}